Evidence for lowered induction of nuclear factor kappa b in activated human t lymphocytes during aging

Gerontology

Volumn 42, Issue 3, 1996, Pages 137-146

  Trebilcock, Gina Uken ^a   Ponnappan, Usha ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Aging; Anti CD3; Inhibitor kappa B; Nuclear factor kappa B; Phorbol myristate acetate; Tumor necrosis factor alpha

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2 RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CYTOSOL; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; PROTEIN INDUCTION; SENESCENCE; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIGENS, CD3; CARCINOGENS; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; NF-KAPPA B; OLIGONUCLEOTIDE PROBES; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029900649     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000213785     Document Type: Article

References (32)

1. Miller R A: Aging and immune function, lnt Rev Cytol 1991:124:187-215.
2. Schwab R, Hausman PB, Rinnoov-Kan F, Wckslcr ME: Immunological studies of ageing, X, Impaired T lymphocytes and normal monocyte response from elderly humans to the mitogenic antibodies OKT3 and Leu 4. Immunology 1985:55:677- 684.
3. Song L, Kim YH, Chopra RK, Proust JJ, Nagel JE, Nordin AA, Adler WH: Age related effects in T cell activation and proliferation, Exp Gerontol 1993;28:313-321.
4. Nagel JE, Chopra RK, Chrest FJ, McCoy MT, Schneider EL, Holbrook NJ, Adler WH: Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phyto-hemagglutinin-stimulated cells from elderly donors, J Clin Invest 1988; 81:1096-1102.
5. Negoro S, Hara H, Miyata S, Saiki O, Tanaka T, Yoshizaki K, Igarashi T: Mechanisms of age-related decline in antigen-specific T cell proliferative response: 1L-2 receptor expression and recombinant IL-2 induced proliferative response of purified Tac-positive T cells, Mech Age Dev 1986;36:223-241.
6. Shi J, Miller RA: Tyrosine-specific protein phosphorylation in response to anti-CD3 antibody is diminished in old mice, J Gerontol 1992:47: B147-B153.
7. Proust JJ, Filburn CR, Harrison SA, Buchholz MA, Nordin AA: Agc-rc-latcd defect in signal transduction during lectin activation of murine T lymphocytes, J Immunol 1987; 139: 1472-1478.
8. Varga ZS, Bressani N, Zaid A-M, Bene L, Fulop T, Leovcy A, Fabris N, Damjanovich S: Cell surface markers, inositol phosphate levels and membrane potential oflympho-cytcs from young and old human patients, Immunol Lett 1989/1990; 23:275-280.
9. Gupta S: Membrane signal transduction in T cells in aging humans, Ann NY Acad Sci 1989:568:277-282.
10. Thoman ML, Weigle WO: Partial restoration of Con A-induced proliferation, IL-2 receptor expression, and IL-2 synthesis in aged murine lymphocytes by phorbol myristatc acetate and ionomycin, Cell Immunol 1988; 14
11. Chopra RK, Holbrook NJ, Powers DC, McCoy MT, Adler WH, Nagel JE: Interleukin 2. interleukin 2 receptor, and interferon-y synthesis and mRNA expression in phorbol myristate acetate and calcium ion-ophorc A23187-stimulated T cells from elderly humans, Clin Immunol Immunopathol 1989:53:297-308.
12. Liou H-C, Baltimore D: Regulation of the NF-kappa Brel transcription factor and I kappa B inhibitor system, Curr Opin Cell Biol 1993;5: 477-487.
13. Grilli M, Chiu JJ-S, Lcnardo MJ: NF-kappa B and Rel: Participants in a multiform transcriptional regulatory system, Int Rev Cytol 1993; 143:1-62.
14. Baeuerle PA, Henkel T: Function and activation of NF-kappa B in the immune system, Annu Rev Immunol 1994;12:141-179.
15. Hoyos B, Ballard DW, Bohnlcin F, Siekevitz M, Greene WC: Kappa B-specific DNA binding proteins: Role in the regulation of human interleukin-2 gene expression, Science 1989: 244:457-460.
16. Shibuya H, Yoneyama M, Tanigu-chi T: Involvement of a common transcription factor in the regulated expression of IL-2 and 11.-2 receptor genes, Int Immunol 1989;1:43-49.
17. Lowcnthal JW, Ballard DW, Bohn-lein E, Greene WC: Tumor necrosis factor a induces proteins that bind specifically to xB-like enhancer elements and regulate interleukin 2 receptor a-chain gene expression in primary human T lymphocytes, Proc Natl Acad Sci USA 1989;86: 2331-2335.
18. Narayanan R, Klement JF, Ruben SM, Higgins KA, Rosen CA: Identification of a naturally occurring transforming variant of the p65 subunit of NF-Kappa B, Science 1992; 256:367-370.
19. Beauparlant P, Kwan I, Bitar R, Chou P, Koromilas AE, Sonenbcrg N, Hiscott J: Disruption of I kappa B alpha regulation by antisensc RNA expression leads to malignant transformation, Oncogene 1994:9: 3189-3197.
20. Dignam JD, Lebowitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei, Nucl Acids Res 1983:11: 1475-1489.
21. Jain J, McCaffrey PG, Valge-Archer VE, Rao A: Nuclear factor of activated T cells contains Fos and Jun, Nature 1992;356:802-804.
22. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protcin-dye binding, Anal Biochem 1976:72: 248-254.
23. Sen R, Baltimore D: Multiple nuclear factors interact with the immunoglobulin enhancer sequences, Cell 1986;46:705-716.
24. Davis LG, Dibncr MD, Battey JF: Basic Methods in Molecular Biology, Amsterdam, Elsevier, 1986.
25. Jamieson C, McCaffrey PG, Rao A, Sen R: Physiologic activation of T cells via the T cell receptor induces NF-xB, J Immunol 1991; 147:416- 420.
26. Meichle A, Schutze S, Hcnsel G, Brunsing D, Kronke M: Protein kinase C independent activation of nuclear factor xB by tumor necrosis factor, J Biol Chent 1990:265:8339-8343.
27. Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M: TNF activates NF-kappa B by phosphatidylcholine-specific phos-pholipase C-induced ‘acidic’ sphingomyelin breakdown, Cell 1992:71: 765-776.
28. Miyamoto S, Schmitt MJ, Verma I: Qualitative changes in the subunit composition of xB-binding complexes during murine B-cell differentiation, Proc Natl Acad Sci USA 1994;91:5056-5060.
29. Henkel T, Machleidt T, Alkalay I, Kronke M, Ben-Neriah Y, Baeuerle P: Rapid proteolysis of IxB-u is necessary for activation of transcription factor NF-xB, Nature 1993:365: 182-185.
30. Tracnckner EB, Wilk S, Baeuerle PA: A proteasome inhibitor prevents activation of NF-xB and stabilizes a newly phosphorylated form of IxB-a that is still bound to NF-kB, EMBO J 1994; 13:5433-5441.
31. Pimentel-Muinos FX, Munoz-Fer-nandez MA, Fresno M: Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokincs, J Immunol 1994:152:5714-5722.
32. Pimentel-Muinos FX, Mazana J, Fresno M: Regulation of intcrleu-kin-2 receptor a chain expression and nuclear factor-xB activation by protein kinase C in T lymphocytes, J Biol Client 1994:269:24424-24429